VG
Viking Global Investors LP cut its BMRN stake below 5%
Viking Global Investors LP reported owning 4.8% of Biomarin Pharmaceutical Inc (BMRN) (9,356,178 shares) in a Schedule 13G filed Nov 21, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 21, 2026
- Source
- Schedule 13G